Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Duvic

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1996
Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasisS Nagpal, S M Thacher, S Patel, et al.
The Journal of Investigative Dermatology|April 1, 1994
Keratinocyte transglutaminase expression varies in squamous cell carcinomasM Duvic, D C Nelson, M Annarella, et al.
The Journal of Investigative Dermatology|July 1, 1992
Type I keratinocyte transglutaminase: expression in human skin and psoriasisW T Schroeder, S M Thacher, S Stewart-Galetka, et al.
Genomics|November 1, 1990
Myogenin is in an evolutionarily conserved linkage group on human chromosome 1q31-q41 and unlinked to other mapped muscle regulatory factor genesE Olson, D Edmondson, W E Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapyA H Sarris, I Braunschweig, L J Medeiros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosisA H Sarris, R Luthra, V Papadimitracopoulou, et al.
Blood|September 1, 1996
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosisA H Sarris, R Luthra, V Papadimitracopoulou, et al.
American Journal of Medical Genetics|September 19, 1997
Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagenP H Byers, M Duvic, M Atkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomasA H Sarris, D Daliani, R Ulmer, et al.
Journal of the American Academy of Dermatology|May 23, 2001
A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphomaM Duvic, E A Olsen, G A Omura, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|December 1, 1996
Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acid receptor-specific retinoid: insight into the mechanism of retinoid action in psoriasisS Nagpal, S M Thacher, S Patel, et al.
The Journal of Investigative Dermatology|April 1, 1994
Keratinocyte transglutaminase expression varies in squamous cell carcinomasM Duvic, D C Nelson, M Annarella, et al.
The Journal of Investigative Dermatology|July 1, 1992
Type I keratinocyte transglutaminase: expression in human skin and psoriasisW T Schroeder, S M Thacher, S Stewart-Galetka, et al.
Genomics|November 1, 1990
Myogenin is in an evolutionarily conserved linkage group on human chromosome 1q31-q41 and unlinked to other mapped muscle regulatory factor genesE Olson, D Edmondson, W E Wright, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapyA H Sarris, I Braunschweig, L J Medeiros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Long-range amplification of genomic DNA detects the t(2;5)(p23;q35) in anaplastic large-cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosisA H Sarris, R Luthra, V Papadimitracopoulou, et al.
Blood|September 1, 1996
Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosisA H Sarris, R Luthra, V Papadimitracopoulou, et al.
American Journal of Medical Genetics|September 19, 1997
Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagenP H Byers, M Duvic, M Atkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomasA H Sarris, D Daliani, R Ulmer, et al.
Journal of the American Academy of Dermatology|May 23, 2001
A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphomaM Duvic, E A Olsen, G A Omura, et al.
Pageof 20